Sinopharm
1099.HK
#1985
Rank
โ‚น703.58 B
Marketcap
โ‚น225.46
Share price
0.25%
Change (1 day)
19.48%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): โ‚น197.04 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.05 Billion. In 2022 the company made an earning of โ‚น276.97 Billion a decrease over its 2021 earnings that were of โ‚น281.81 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚น197.04 B-28.86%
2022 โ‚น276.97 B-1.72%
2021โ‚น281.81 B11.7%
2020โ‚น252.29 B18.44%
2019โ‚น213.00 B10.85%
2018โ‚น192.16 B3.05%
2017โ‚น186.47 B36.48%
2016โ‚น136.63 B7.11%
2015โ‚น127.56 B12.38%
2014โ‚น113.51 B25.05%
2013โ‚น90.77 B22.54%
2012โ‚น74.08 B35.43%
2011โ‚น54.70 B52.24%
2010โ‚น35.92 B30.99%
2009โ‚น27.42 B60.59%
2008โ‚น17.08 B48.29%
2007โ‚น11.51 B123.29%
2006โ‚น5.15 B